Bacteriophage therapy (BT) uses bacteriophages to treat pathogenic bacteria and is an
emerging strategy against multidrug-resistant (MDR) infections. Experience in solid organ …

There are no effective clinical treatments for volumetric muscle loss (VML) resulting from
traumatic injury, tumor excision, or other degenerative diseases of skeletal muscle. The goal of …

Transplantation of solid organs from donors with active SARS-CoV-2 infection has been
advised against due to the possibility of disease transmission to the recipient. However, with the …

Background Drive-line infections (DLIs) frequently complicate ventricular assist device (VAD)
support. We sought to describe the detailed effects of DLIs over time in patients with …

Coronavirus disease-19 has had a marked impact on the transplant population and processes
of care for transplant centers and organ allocation. Several single-center studies have …

BACKGROUND: Left ventricular (LV) remodeling after myocardial infarction (MI) commonly
causes infarct expansion (IE). This study sought to interrupt IE through microinjections of a …

BACKGROUND Despite advances in device technology and treatment strategies, infection
remains a major cause of adverse events (AEs) in mechanical circulatory support (MCS) …

Invasive fungal infections (IFIs) are associated with a high mortality rate for liver transplantation
(LT) recipients. To study the incidence of and risk factors for IFIs in LT recipients and the …

Study Objective. To determine if milk thistle (silymarin) alters the pharmacokinetics of indinavir.
Design. Sequential crossover trial. Setting. General clinical research center. Subjects. …

SARS‐CoV2, first described in December 2019, was declared a pandemic by the World Health
Organization in March 2020. Various surgical and medical societies promptly published …